Question from Deputy Pádraig OSullivan - PQ 30453-26
Deputy O'Sullivan asked about the Children's Disability Network Team (CDNT) waiting lists in Cork. Read the HSE response.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 31 to 40 of 4536 results
Question from Deputy Mary Lou McDonald - PQ 30052-26
Deputy McDonald asked about the number of cervical screening tests conducted from 2023to 2025. Read the HSE response.
- Published date:
- :
Question from Deputy Cormac Devlin - PQ 30915-26
Deputy Devlin asked about an application received by the HSE for pricing and reimbursement of baricitinib. Read the HSE response.
- Published date:
- :
Question from Deputy Paul Lawless - PQ 29750-26
Deputy Ward asked about the infection prevention and control procedures in place at Mayo University Hospital. Read the HSE response.
- Published date:
- :
Question from Deputy Paul Lawless - PQ 29749-26
Deputy Lawless asked about the current visitor policy at Mayo University Hospital. Read the HSE response.
- Published date:
- :
Question from Deputy Claire Kerrane - PQ 30322-26
Deputy Kerrane asked will the medical card scheme be extended to cover ADHD assessments for adults. Read the HSE response.
- Published date:
- :
Question from Deputy Mairéad Farrell - PQ 30258-26
Deputy Farrell asked about the number of consultant psychiatrists posts in Galway Mental Health Services. Read the HSE response.
- Published date:
- :
Question from Deputy Mary Lou McDonald - PQ 30051-26
Deputy McDonald asked about cervical screening for women under 25 years of age. Read the HSE response.
- Published date:
- :
Question from Deputy Paul Lawless - PQ 29746-26
Deputy Lawless asked about compliance with cleaning and hygiene protocols at Mayo University Hospital. Read the HSE response.
- Published date:
- :
Question from Deputy Cormac Devlin - PQ 30914-26
Deputy Devlin asked about an update on the NCPE appraisal of ritlecitinib (litfulo) for severe alopecia areata. Read the HSE response.
- Published date:
- :